Expression of glucose transporter-1 and -3 in the head and neck carcinoma - The correlation of the expression with the biological behaviors

ORL

Volumn 70, Issue 3, 2008, Pages 189-194

  Zhou, Shuihong ^a   Wang, Shenqing ^a   Wu, Qiuliang ^a   Fan, Jun ^a   Wang, Qinying ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Glucose transporter 1; Glucose transporter 3; Head and neck carcinoma

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC CORRELATION; GLUCOSE TRANSPORT; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42649112735     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000124293     Document Type: Article

References (13)

1. Zhang J, Liu Z, Liu H, Li Y, Li L: Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells. Chin Med J (Engl) 2000;113:508-513.
2. Lu C, Ye R, Yang Q, Yang X, Li H, Li Y: Gene expression of glucose transporters and its regulation by glucose in mesothelial cells. Chin Med J (Engl) 2001;114:477-480.
3. Cooper R, Sarioglu S, Sokmen S, Fuzun M, Kupelioglu A, Valentine H, Gorken IB, Airley R, West C: Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? Br J Cancer 2003;89:870-876.
4. Ito H, Duxbury M, Zinner MJ, Ashley SW, Whang EE: Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity. Surgery 2004;136:548-556.
5. Chung JK, Lee YJ, Kim SK, Jeong JM, Lee DS, Lee MC: Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer. Nucl Med Commun 2004;25:11-17.
6. Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y, van Tinteren H, Harris AL, van Diest PJ, van der Wall E: Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005;58:172-177.
7. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL: Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 1996;37:1042-1047.
8. Reisser C, Eichhorn K, Herold-Mende C, Born AI, Bannasch P: Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer 1999;80:194-198.
9. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C: Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001;7:928-934.
10. Mamede M, Higashi T, Kitaichi M, Ishizu K, Ishimori T, Nakamoto Y, Yanagihara K, Li M, Tanaka F, Wada H, Manabe T, Saga T: [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 2005;7:369-379.
11. Tohma T, Okazumi S, Makino H, Cho A, Mochiduki R, Shuto K, Kudo H, Matsubara K, Gunji H, Ochiai T: Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology 2005;52:486-490.
12. Zingone A, Seidel J, Aloj L, Caraco C, Vaquero JJ, Jagoda EM, Chou JY, Green MV, Eckelman WC: Monitoring the correction of glycogen storage disease type 1a in a mouse model using [18F]FDG and a dedicated animal scanner. Life Sci 2002;71:1293-1301.
13. Mellanen P, Minn H, Grenman R, Harkonen P: Expression of glucose transporters in head-and-neck tumors. Int J Cancer 1994;56:622-629.